We are live on ! Find out more
ADCT icon

ADC Therapeutics
ADCT

41 hedge funds and large institutions have $1B invested in ADC Therapeutics in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

30.48% more ownership

Funds ownership: 0% → 30.48% (+30%)

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
0.84%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$210M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$199M
3
BBA
Baker Bros. Advisors
New York
+$64M
4
MF
Magnetar Financial
Illinois
+$59.3M
5
GH
Grosvenor Holdings
Illinois
+$48.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$259M +$210M +5,525,870 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$245M +$199M +5,244,231 New
BBA
3
Baker Bros. Advisors
New York
$79M +$64M +1,687,500 New
MF
4
Magnetar Financial
Illinois
$64.4M +$59.3M +1,563,438 New
GH
5
Grosvenor Holdings
Illinois
$59.8M +$48.5M +1,277,212 New
JP Morgan Chase
6
JP Morgan Chase
New York
$53.5M +$43.4M +1,142,773 New
AllianceBernstein
7
AllianceBernstein
Tennessee
$43.4M +$35.2M +927,577 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$27.7M +$22.5M +592,251 New
MB
9
MPM BioImpact
Massachusetts
$25.3M +$20.5M +539,648 New
DM
10
Deerfield Management
New York
$23.4M +$19M +500,000 New
HA
11
HHLR Advisors
Cayman Islands
$23.4M +$19M +500,000 New
MICM
12
Matthews International Capital Management
California
$11.2M +$9.09M +239,500 New
PI
13
PEAK6 Investments
Illinois
$10.9M +$8.85M +233,112 New
WG
14
Winton Group
United Kingdom
$10.7M +$8.69M +229,000 New
SCM
15
Suvretta Capital Management
New York
$8.2M +$6.65M +175,090 New
BlackRock
16
BlackRock
New York
$7.7M +$6.24M +164,500 New
Principal Financial Group
17
Principal Financial Group
Iowa
$7.17M +$5.81M +153,087 New
EAM
18
Eventide Asset Management
Massachusetts
$7.02M +$5.69M +150,000 New
AG
19
Artal Group
Luxembourg
$6.37M +$5.16M +136,000 New
BCM
20
Burrage Capital Management
Massachusetts
$6.32M +$5.12M +134,912 New
UBS AM
21
UBS AM
Illinois
$3.68M +$2.98M +78,618 New
Ameriprise
22
Ameriprise
Minnesota
$3.03M +$2.46M +64,710 New
CCM
23
CAAS Capital Management
New York
$1.64M +$1.33M +35,000 New
FAM
24
Fred Alger Management
New York
$1.64M +$1.33M +35,000 New
MWNA
25
Marshall Wace North America
New York
$1.45M +$1.18M +30,990 New
1
2

ADCT Hedge Fund Activity: Q2 2020 in Review

41 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in ADC Therapeutics (ADCT) for Q2 2020, worth a combined $1B.

Buyers outnumbered sellers: 41 funds opened new ADCT positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $210M.

  • 41 institutional investors held ADC Therapeutics (ADCT) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1B of ADC Therapeutics stock for Q2 2020.
  • 41 funds opened new ADC Therapeutics positions in Q2 2020 and 0 closed out, a net change of +41 holders.
  • The largest ADC Therapeutics buyer in Q2 2020 was Redmile Group, an estimated $210M added.

Based on aggregated 13F filings for Q2 2020.